Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      Home/Newsroom/Communicable diseases & vaccines

      Infectious diseases & vaccines

      Communicable diseases & vaccines
      European Commission Approves Expanded Use of HIV-1 Therapy
      EDURANT® (rilpivirine) in Younger Pediatric Patients
      October 28, 2024
      Belgium
      Read more
      Communicable diseases & vaccines
      Janssen and Global Partners to Discontinue Phase 3 Mosaico HIV Vaccine Clinical Trial
      January 18, 2023
      Read more
      Communicable diseases & vaccines
      Janssen Enters into Agreement with Sanofi to Advance Potential First-In-Class Vaccine Program
      October 3, 2023
      United States
      Read more
      Communicable diseases & vaccines
      U.S. FDA Approves EDURANT® PED (rilpivirine) for Certain Pediatric Patients Living with HIV-1
      March 19, 2024
      United States
      Read more
      Communicable diseases & vaccines
      World Health Organization Updated Emergency Use Listing Recommends Johnson & Johnson COVID-19 Vaccine for Booster Use
      April 6, 2022
      United States
      Read more